title: Androgen deprivation with radiotherapy: how long is long enough?
authors.affiliation: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: pjgray@partners.org.
authors.forename: Phillip J
authors.initials: PJ
authors.lastname: Gray
authors.affiliation: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: Anthony L
authors.initials: AL
authors.lastname: Zietman
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D059248:Chemoradiotherapy / Q000379:methods*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal